Jane Street Group, LLC Myriad Genetics Inc Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 16, 2021	SELL	$29.97 - $36.66 $8,991 - $10,997	-300 Reduced 4.48%	6,400 $207,000
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $139,645 - $179,355	-5,500 Reduced 45.08%	6,700 $205,000
Q4 2020 Feb 17, 2021	SELL	$12.16 - $19.77 $15,808 - $25,701	-1,300 Reduced 9.63%	12,200 $241,000
Q2 2020 Aug 17, 2020	BUY	$10.69 - $16.49 $47,036 - $72,556	4,400 Added 48.35%	13,500 $153,000
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $52,991 - $112,992	-2,400 Reduced 20.87%	9,100 $261,000
Q2 2019 Aug 15, 2019	BUY	$22.67 - $35.0 $260,705 - $402,500	11,500 New	11,500 $319,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.